These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2271516)

  • 1. Regulation of coagulation by a multivalent Kunitz-type inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Biochemistry; 1990 Aug; 29(33):7539-46. PubMed ID: 2271516
    [No Abstract]   [Full Text] [Related]  

  • 2. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of leukocyte elastase on tissue factor pathway inhibitor.
    Higuchi DA; Wun TC; Likert KM; Broze GJ
    Blood; 1992 Apr; 79(7):1712-9. PubMed ID: 1558967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced inhibition of tissue factor by the extended form of an endothelial cell glycoprotein (an extrinsic pathway inhibitor).
    Colburn P; Crabb JW; Buonassisi V
    J Cell Physiol; 1991 Aug; 148(2):320-6. PubMed ID: 1880157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cDNA sequence of rabbit tissue factor pathway inhibitor.
    Warn-Cramer BJ; Broze GJ; Komives EA
    Nucleic Acids Res; 1992 Jul; 20(13):3548. PubMed ID: 1630940
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of tissue factor pathway inhibitor in a revised coagulation cascade.
    Broze GJ
    Semin Hematol; 1992 Jul; 29(3):159-69. PubMed ID: 1641662
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):221-2. PubMed ID: 1318759
    [No Abstract]   [Full Text] [Related]  

  • 8. Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation.
    Lindahl AK; Abildgaard U; Larsen ML; Aamodt LM; Nordfang O; Beck TC
    Thromb Res Suppl; 1991; 14():39-48. PubMed ID: 1658969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the C-terminal domain in the inhibitory functions of tissue factor pathway inhibitor.
    Ettelaie C; Adam JM; James NJ; Oke AO; Harrison JA; Bunce TD; Bruckdorfer KR
    FEBS Lett; 1999 Dec; 463(3):341-4. PubMed ID: 10606750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA sequence of rabbit lipoprotein-associated coagulation inhibitor.
    Wesselschmidt RL; Girard TJ; Broze GJ
    Nucleic Acids Res; 1990 Nov; 18(21):6440. PubMed ID: 2136251
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism.
    Rapaport SI
    Blood; 1989 Feb; 73(2):359-65. PubMed ID: 2644974
    [No Abstract]   [Full Text] [Related]  

  • 13. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity.
    Nordfang O; Bjørn SE; Valentin S; Nielsen LS; Wildgoose P; Beck TC; Hedner U
    Biochemistry; 1991 Oct; 30(43):10371-6. PubMed ID: 1931960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.
    Sandset PM; Abildgaard U; Pettersen M
    Thromb Res; 1987 Aug; 47(4):389-400. PubMed ID: 3499007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipoprotein-associated coagulation inhibitor.
    Broze GJ; Girard TJ; Novotny WF
    Prog Hemost Thromb; 1991; 10():243-68. PubMed ID: 2008533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor revisited.
    Hjort PF; Sandset PM; Abildgaard U; Rao LV; Mast A; Ott I; Bajaj SP
    J Thromb Haemost; 2004 Dec; 2(12):2241-9. PubMed ID: 15613032
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.
    Day KC; Hoffman LC; Palmier MO; Kretzmer KK; Huang MD; Pyla EY; Spokas E; Broze GJ; Warren TG; Wun TC
    Blood; 1990 Oct; 76(8):1538-45. PubMed ID: 2207329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization.
    Van der Logt CP; Kluck PM; Wiegant J; Landegent JE; Reitsma PH
    Hum Genet; 1992 Jul; 89(5):577-8. PubMed ID: 1353057
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.